Anti-Human CD166 (ALCAM) In Vivo Antibody - Low Endotoxin

(No reviews yet) Write a Review
SKU:
IVMB0248
Product Type:
In Vivo Monoclonal Antibody
Clone:
3A6
Protein:
CD166
Isotype:
IgG1 k
Reactivity:
Human
Synonyms:
CD6 ligand
Activated Leukocyte Cell Adhesion Molecule (ALCAM)
Research Area:
Cell Adhesion
Cell Biology
Immunology
Neuroscience
Synaptic Biology
Endotoxin Level:
Low Endotoxin
Host Species:
Mouse
Applications:
FC
IF
IF Microscopy
IHC
In Vivo
IP
Frequently bought together:

Description

Product Name:Anti-Human CD166 (ALCAM) In Vivo Antibody - Low Endotoxin
Product Code:IVMB0248
Size:1 mg, 5 mg, 25 mg, 50 mg, 100 mg
Clone:3A6
Product Type:Monoclonal Antibody
Synonyms:CD6 ligand, Activated Leukocyte Cell Adhesion Molecule (ALCAM)
Isotype:IgG1 k
Reactivity:Human
Applications:FC, IF, IF Microscopy, IHC, In Vivo, IP
Formulation:This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration.
Endotoxin Level:< 1.0 EU/mg as determined by the LAL method
Purity:≥95% monomer by analytical SEC ⋅ >95% by SDS Page
Product Preparation:Functional grade preclinical antibodies are manufactured in an animal free facility using in vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.
Applications:FC, IF, IF Microscopy, IHC, In Vivo, IP
Reactivity:Human
Host Species:Mouse
Specificity:3A6 activity is directed against human CD166 (ALCAM) and cross-reacts with ovine tissues.
Antigen Distribution:CD166 is expressed on neurons, activated leukocytes, hematopoietic stem cells, mesenchymal stem cells, bone marrow stromal cells, activated T cells, activated B cells, activated monocytes, thymic epithelial cells, vascular endothelial cells, fibroblasts, keratinocytes, myeloid progenitors, tumor cells, and cancer stem cells.
Immunogen:Cultured human thymic epithelial cells
Concentration:≥ 5.0 mg/ml
Endotoxin Level:< 1.0 EU/mg as determined by the LAL method
Formulation:This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration.
Purity:≥95% monomer by analytical SEC ⋅ >95% by SDS Page
Preparation:Functional grade preclinical antibodies are manufactured in an animal free facility using in vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.
Storage and Handling:Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -70°C. Avoid Repeated Freeze Thaw Cycles.

Activated leukocyte cell adhesion molecule (ALCAM) is a member of the immunoglobulin superfamily and a cell surface glycoprotein1. In normal physiology, ALCAM functions in cell adhesion, is known to promote T cell activation and proliferation by interacting with CD6, and functions in angiogenesis, monocyte transmigration, leukocyte intravasation across the blood-brain barrier, hematopoiesis, neurite extension, osteogenesis, and embryonic implantation in the uterus. In cancer, ALCAM is a prognostic marker of disease progression and acts as a modulator of progression by controlling cell proliferation, adhesion, migration, and invasion.

ALCAM participates in homophilic ALCAM-ALCAM interactions as well as numerous heterophilic interactions1. Ligands include CD6, galectin-8, endophilin-A3/galectin-8, CD9, S100B, and ezrin. Additionally, SOSTDC1 is a novel ligand of ALCAM that promotes invasion and facilitates liver metastasis in colorectal cancer through activation of the Src-P13K/AKT pathways2.

ALCAM is a type I transmembrane molecule with a large glycosylated extracellular domain1. Two isoforms have been confirmed at the protein level: ALCAM-Iso1, which is the full length isoform, and ALCAM-Iso2, which lacks exon 13. ALCAM is proteolytically cleaved at its extracellular domain by the transmembrane metalloprotease ADAM17, with ALCAM-Iso2 more susceptible to cleavage.

3A6 was produced by immunizing mice with human thymic epithelial cells and then fusing spleen cells with P3X63Ag8 myeloma cells3. 3A6 cross reacts with ovine mesenchymal stromal cells from iliac crest bone marrow aspirates4.

Research Area:Cell Adhesion, Cell Biology, Immunology, Neuroscience, Synaptic Biology
NCBI Gene Bank ID:214

0 Reviews

View AllClose

Related Products